Literature DB >> 8636172

Unipolar or bipolar prosthesis for displaced intracapsular hip fracture in octogenarians: a randomised prospective study.

S J Calder1, G H Anderson, C Jagger, W M Harper, P J Gregg.   

Abstract

We performed a randomised prospective trial to compare a cemented unipolar prosthesis (Thompson) with a cemented bipolar prosthesis (Monk) in the treatment of displaced intracapsular fractures of the hip in patients over 80 years of age. Patients with a mental test score of less than 5/13 were excluded but the mortality was still about 30% at one year in both groups. We therefore feel that subjective criteria such as the level of pain and the return to the preinjury state are of paramount importance. Two years after operation there was no statistical difference between the rate of complications in the two groups. After adjusting for confounding factors such as differences in the level of function before injury between the groups, the degree of return to the preinjury state was significantly greater (p = 0.04) when using the unipolar prosthesis, which is one-quarter of the price of the bipolar. We cannot therefore justify the use of an expensive bipolar prosthesis in patients over 80 years of age.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8636172

Source DB:  PubMed          Journal:  J Bone Joint Surg Br        ISSN: 0301-620X


  31 in total

Review 1.  Extracts from "clinical evidence": hip fracture.

Authors:  W J Gillespie
Journal:  BMJ       Date:  2001-04-21

2.  Unipolar hemiarthroplasty versus bipolar hemiarthroplasty in patients with displaced femoral neck fractures: a four-year follow-up of a randomised controlled trial.

Authors:  Christian Inngul; Carl-Johan Hedbeck; Richard Blomfeldt; Gunilla Lapidus; Sari Ponzer; Anders Enocson
Journal:  Int Orthop       Date:  2013-12       Impact factor: 3.075

3.  Unipolar hemiarthroplasty versus bipolar hemiarthroplasty in the most elderly patients with displaced femoral neck fractures: a randomised, controlled trial.

Authors:  Carl Johan Hedbeck; Richard Blomfeldt; Gunilla Lapidus; Hans Törnkvist; Sari Ponzer; Jan Tidermark
Journal:  Int Orthop       Date:  2011-02-08       Impact factor: 3.075

4.  Unipolar versus bipolar Exeter hip hemiarthroplasty: a prospective cohort study on 830 consecutive hips in patients with femoral neck fractures.

Authors:  Anders Enocson; Carl Johan Hedbeck; Hans Törnkvist; Jan Tidermark; Lasse J Lapidus
Journal:  Int Orthop       Date:  2011-07-26       Impact factor: 3.075

5.  Choice of approach, but not femoral head size, affects revision rate due to dislocations in THA after femoral neck fracture: results from the Lithuanian Arthroplasty Register.

Authors:  Algimantas Cebatorius; Otto Robertsson; Justinas Stucinskas; Alfredas Smailys; Linas Leonas; Sarunas Tarasevicius
Journal:  Int Orthop       Date:  2014-12-16       Impact factor: 3.075

Review 6.  Bipolar versus monopolar hemiarthroplasty for displaced femur neck fractures: a meta-analysis study.

Authors:  Migliorini Filippo; Arne Driessen; Giorgia Colarossi; Valentin Quack; Markus Tingart; Jörg Eschweiler
Journal:  Eur J Orthop Surg Traumatol       Date:  2019-11-26

7.  Surgical prosthetic treatment.

Authors:  Christian Carulli; Fabrizio Matassi; Roberto Civinini; Marco Villano; Massimo Innocenti
Journal:  Clin Cases Miner Bone Metab       Date:  2010-01

8.  Meta-analysis of randomised controlled trials comparing unipolar with bipolar hemiarthroplasty for displaced femoral-neck fractures.

Authors:  Yang Liu; Xueqiang Tao; Pei Wang; Zheng Zhang; Wenlong Zhang; Quan Qi
Journal:  Int Orthop       Date:  2014-05-10       Impact factor: 3.075

Review 9.  Stability of hip hemiarthroplasties.

Authors:  James Varley; Martyn J Parker
Journal:  Int Orthop       Date:  2004-08-17       Impact factor: 3.075

10.  Prosthetic replacement in femoral neck fracture in the elderly: results and review of the literature.

Authors:  S K S Marya; R Thukral; Chandeep Singh
Journal:  Indian J Orthop       Date:  2008-01       Impact factor: 1.251

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.